CANY
ADAP

Caxton Associates (New York)’s Adaptimmune Therapeutics ADAP Stock Holding History

Caxton Associates (New York)’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,713
Closed -$37.5K – 477
2022
Q4 		$37.5K Buy
+25,713
New +$37.5K ﹤0.01% 412
2022
Q3 		– Sell
-23,034
Closed -$39K – 453
2022
Q2 		$39K Buy
+23,034
New +$39K ﹤0.01% 522